Search results
Results from the WOW.Com Content Network
A 2013 meta-analysis concluded that every use of birth control pills is associated with a modest increase in the risk of breast cancer (relative risk 1.08) and a reduced risk of colorectal cancer (relative risk 0.86) and endometrial cancer (relative risk 0.57). Cervical cancer risk in those infected with HPV is increased. [124]
The side effects of cyproterone acetate (CPA), a steroidal antiandrogen and progestin, including its frequent and rare side effects, have been studied and characterized.It is generally well-tolerated and has a mild side-effect profile, regardless of dosage, when it used as a progestin or antiandrogen in combination with an estrogen such as ethinylestradiol or estradiol valerate in women.
The relative risk was similar to that found for current or recent COCP users (RR 1.16), and, as with COCPs, the increased relative risk decreased over time after stopping, vanished after 10 years, and was consistent with being due to earlier diagnosis or promoting the growth of a preexisting cancer.
There is a mixed effect of combined hormonal contraceptives on the rates of various cancers, with the International Agency for Research on Cancer (IARC) stating: "It was concluded that, if the reported association was causal, the excess risk for breast cancer associated with typical patterns of current use of combined oral contraceptives was ...
Scientists hope findings signal a major breakthrough in tackling leading cause of cancer deaths Lung cancer pill ‘halves risk of death’ Skip to main content
Oral contraceptives are another option, these are commonly known as 'the pill'. These must be taken at the same time every day in order to be the most effective. There are two different options, there is a combined pill that contains both of the hormones estrogen and progestin, and a progestin-only pill. The failure rate of each of these oral ...
The lawsuit was filed in a Texas federal court Friday, roughly four months after the Supreme Court decided against undoing changes to the FDA’s regulations on the abortion pill that expanded ...
A court case that began in Texas has sought to roll back Food and Drug Administration approval of the drug, mifepristone. Lower courts had said that women seeking the drug should face more ...